Compare Johnson & Johnson (JNJ) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs PepsiCo, Inc. — how do they compare? Johnson & Johnson trades at $261.44 (market cap $618.09B), while PepsiCo, Inc. trades at $125.97 (market cap $174.89B). The key difference: Johnson & Johnson is far larger — about 3.5× PepsiCo, Inc.'s market cap, and PepsiCo, Inc. pays the higher dividend (4.61%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and PepsiCo, Inc. for 107 Days on average.
| JNJ | PEP | |
|---|---|---|
Market Cap | $618.09B | $174.89B |
Volume | 6,050,983 | 23,968,864 |
Sector | Health | Consumer Staples |
52-Week High | $278.43 | $170.44 |
52-Week Low | $186.00 | $123.64 |
Typical Hold Time | 129 Days | 107 Days |
Enterprise Value | $646.37B | $215.61B |
Dividend Yield | 2.09% | 4.61% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.
JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.
PepsiCo (PEP) trades at $125.97, up 1.88% today, with a bearish technical signal but strong fundamentals. The stock shows consistent earnings beats, with Q3 2026 EPS of $2.34 exceeding the $2.29 estimate. Revenue grew to $93.93B in 2025, though net income margin dipped to 8.77%. Analysts maintain a consensus price target of $146.77, implying significant upside. Recent news highlights price cuts on snacks like Doritos to address consumer pushback, while institutional holdings saw mixed adjustments.
The outlook for PEP is cautiously optimistic, driven by earnings momentum and a reasonable P/E of 16.14. Risks include competitive pressures and sensitivity to consumer spending. The stock offers a dividend yield near 4%, supporting income-focused investors. Upside potential exists if North American performance improves, but volatility may persist amid macroeconomic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
